Location History:
- Clinton, WA (US) (2013)
- Langley, WA (US) (2008 - 2015)
Company Filing History:
7 out of 2,100 
1 out of 462 
Years Active: 2008-2024
Title: Allan Rettie: Innovator in Drug Response and Disease Diagnosis
Introduction
Allan Rettie is a notable inventor based in Langley, WA (US), recognized for his contributions to the fields of pharmacogenomics and disease diagnosis. With a total of 7 patents, Rettie's work focuses on improving patient care through innovative methods and compositions.
Latest Patents
Rettie's latest patents include significant advancements in the quantitation of GLA proteins by mass spectrometric analysis. His methods of LC-MS/MS quantification of γ-carboxylated proteins in plasma, serum, or blood, including dried blood spots, are designed to determine patient-specific dosing of anticoagulant drugs and aid in the diagnosis of liver diseases, such as hepatocellular carcinoma. Additionally, he has developed methods and compositions for predicting drug responses, particularly in determining individualized Warfarin dosages based on the genotype of DNA polymorphisms and haplotypes derived from the VKORC1 gene.
Career Highlights
Throughout his career, Allan Rettie has made significant strides in the medical and pharmaceutical fields. His innovative approaches have the potential to transform how healthcare providers manage anticoagulant therapies and diagnose liver conditions.
Collaborations
Rettie has collaborated with esteemed colleagues, including Mark J Rieder and Bhagwat Prasad, enhancing the impact of his research and inventions.
Conclusion
Allan Rettie's contributions to drug response prediction and disease diagnosis exemplify the importance of innovation in healthcare. His work continues to pave the way for personalized medicine and improved patient outcomes.